Login / Signup

Colony stimulating factors for prophylaxis of chemotherapy-induced neutropenia in children.

Heeyeon KimShaker A Mousa
Published in: Expert review of clinical pharmacology (2022)
Filgrastim 5 mcg/kg/day or pegfilgrastim 100 mcg/kg single dose is appropriate when given at least 24 hours or after the chemotherapy in pediatric patients who weigh 45 kg or more. More prospective randomized trials are necessary to further investigate the efficacy and safety of G-CSFs in children with different types of cancer.
Keyphrases
  • chemotherapy induced
  • young adults
  • childhood cancer
  • squamous cell carcinoma
  • lymph node metastasis